BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34678661)

  • 1. Generation of a homozygous MYH7 gene knockout human embryonic stem cell line (WAe009-A-69) using an episomal vector-based CRISPR/Cas9 system.
    Guo T; Jiang Y; Song Y; Ma S; Chang Y; Zhang S; Wang H; Dong T; Jiang H; Lu W
    Stem Cell Res; 2021 Dec; 57():102566. PubMed ID: 34678661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
    Wu F; Li X; Bai R; Li Y; Gao J; Lan F
    Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a TBX20 homozygous knockout stem cell line (WAe009-A-1E) by episomal vector-based CRISPR/Cas9 system.
    Hou X; Mu J
    Stem Cell Res; 2024 Jun; 77():103384. PubMed ID: 38479330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
    Qin Z; Sun L; Sun X; Su H; Gao X
    Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a human embryonic stem cell line (WAe009-A-78) carrying homozygous TBX18 knockout.
    Xu Q; Zhao T; Zhang Y; Fan W; Yan Y; Lan F
    Stem Cell Res; 2022 Jul; 62():102804. PubMed ID: 35533514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
    Wang W; Bai R; Song X
    Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a ISL1 homozygous knockout stem cell line (WAe009-A-1G) by episomal vector-based CRISPR/Cas9 system.
    Hou X; Fan W; Zeng J; Gao Z; Wan J; Liao B
    Stem Cell Res; 2024 Apr; 76():103376. PubMed ID: 38452706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a FOXH1 homozygous knockout human embryonic stem cell line by CRISPR/Cas9 system.
    Zhang T; Huang W; Xue X
    Stem Cell Res; 2020 Dec; 50():102121. PubMed ID: 33348200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a human MYH6 compound heterozygous knockout hESC line to model cardiomyopathy and congenital heart defects by CRISPR/Cas9 system.
    Hao E; Zhang G; Mu L; Ma N; Wang T
    Stem Cell Res; 2020 Dec; 50():102128. PubMed ID: 33360099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
    Ross SB; Fraser ST; Nowak N; Semsarian C
    Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a homozygous HDAC6 knockout human embryonic stem cell line by CRISPR/Cas9 editing.
    Xie L; Huang J; Li X; Dai L; Lin X; Zhang J; Luo J; Zhang W
    Stem Cell Res; 2019 Dec; 41():101610. PubMed ID: 31775087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a homozygous S100A1 knockout human embryonic stem cell line (WAe009-A-73) by the CRISPR/Cas9 editing system.
    Zhang S; Guo T; Song Y; Jiang M; Jiang Y; Dong T; Zhang S; Wang H; Hou X
    Stem Cell Res; 2022 Mar; 59():102631. PubMed ID: 34953326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.
    Zhang P; Wang H; Li S; Guo T; Zhang R; Zhou P; Ding S
    Stem Cell Res; 2022 Oct; 64():102924. PubMed ID: 36182708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a TBX5 homozygous knockout embryonic stem cell line (WAe009-A-45) by CRISPR/Cas9 genome editing.
    Zhao T; Bai R; Wu F; Lu WJ; Zhang J
    Stem Cell Res; 2021 Mar; 51():102156. PubMed ID: 33497883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a homozygous COX6A2 knockout human embryonic stem cell line (WAe009-A-47) via an epiCRISPR/Cas9 system.
    Hang C; Song Y; Wu F; Dong T; Jiang M; Saleem A; Zhang S; Chang Y; Lu W; Cui M
    Stem Cell Res; 2021 Jan; 50():102152. PubMed ID: 33418201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a KCNQ1 homozygous knockout human embryonic stem cell line by episomal vector-based CRISPR/Cas9 system.
    Liu X; Zhang S; Chang Y; Wu F; Bai R
    Stem Cell Res; 2021 Aug; 55():102467. PubMed ID: 34343827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 mediated establishment of a human CSRP3 compound heterozygous knockout hESC line to model cardiomyopathy and heart failure.
    Sun L; Li J; Li E; Niu S; Qin Z; Zhi Q; Zhao J; Xiong H; Li Y; Jian L; Zhang L
    Stem Cell Res; 2020 Dec; 49():102077. PubMed ID: 33176267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system.
    Dong T; Zhang S; Chang Y; Bai R; Jiang Y; Ma S; Li Y; Jiang HF; Lu WJ
    Stem Cell Res; 2021 Mar; 51():102196. PubMed ID: 33524674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.
    Sun W; Li X; Dong J; Zhou Y
    Stem Cell Res; 2024 Feb; 74():103284. PubMed ID: 38118206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.
    Lu F; Gao Y; Li E
    Stem Cell Res; 2023 Sep; 71():103162. PubMed ID: 37429070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.